Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (83)

2024

  1. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

    Neurologia, Vol. 39, Núm. 2, pp. 196-208

  2. Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis

    Journal of Neurochemistry, Vol. 168, Núm. 5, pp. 744-759

2023

  1. Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs

    JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403

  2. Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

    Antioxidants, Vol. 12, Núm. 2

  3. Lipid Adaptations against Oxidative Challenge in the Healthy Adult Human Brain

    Antioxidants, Vol. 12, Núm. 1

  4. Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1887-1916

  5. Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity

    The Journal of clinical investigation, Vol. 133, Núm. 10

2022

  1. A motor neuron disease mouse model reveals a non-canonical profile of senescence biomarkers

    Disease models & mechanisms, Vol. 15, Núm. 8

  2. Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy

    Acta Neuropathologica, Vol. 144, Núm. 2, pp. 241-258

  3. Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology

    Frontiers in immunology, Vol. 13, pp. 842354

  4. Cardiac fibroblasts display endurance to ischemia, high ROS control and elevated respiration regulated by the JAK2/STAT pathway

    FEBS Journal, Vol. 289, Núm. 9, pp. 2540-2561

  5. Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders

    The Lancet Neurology, Vol. 21, Núm. 10, pp. 899-910

  6. Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    Neurologia, Vol. 37, Núm. 8, pp. 615-630

  7. Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology

    Multiple Sclerosis and Related Disorders, Vol. 63

  8. Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model

    Neuropathology and Applied Neurobiology, Vol. 48, Núm. 1

  9. Selective brain regional changes in lipid profile with human aging

    GeroScience, Vol. 44, Núm. 2, pp. 763-783

2021

  1. Age-related changes in lipidome of rat frontal cortex and cerebellum are partially reversed by methionine restriction applied in old age

    International Journal of Molecular Sciences, Vol. 22, Núm. 22

  2. Cell stress induces mislocalization of transcription factors with mitochondrial enrichment

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  3. Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease

    Brain Pathology, Vol. 31, Núm. 6

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382